| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |